Author:
Park Won,Suh Chang-Hee,Shim Seung Cheol,Molina Francisco Fidencio Cons,Jeka Slawomir,Medina-Rodriguez Francisco G.,Hrycaj Pawel,Wiland Piotr,Lee Eun Young,Shesternya Pavel,Kovalenko Volodymyr,Myasoutova Leysan,Stanislav Marina,Radominski Sebastiao,Lim Mie Jin,Choe Jung-Yoon,Lee Sang Joon,Lee Sung Young,Kim Sung Hwan,Yoo Dae Hyun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference23 articles.
1. Weiner GJ. Rituximab: mechanism of action. Sem Hematol. 2010;47:115–23.
2. Edwards JCW, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol. 2006;6:394–403.
3. Lopez-Olivo MA, Amezaga Urruela M, McGahan L, et al. Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev. 2015;1:CD007356.
4. Tak PP, Rigby W, Rubbert-Roth A, et al. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Ann Rheum Dis. 2012;71:351–7.
5. Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68:1–26.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献